Lung Disease in Rheumatoid Arthritis

Lee, 2005, Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease, Chest, 127, 2019, 10.1378/chest.127.6.2019

Gabriel, 2003, Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years, Arthritis Rheum, 48, 54, 10.1002/art.10705

Turesson, 2002, Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis, J Rheumatol, 29, 62

Bilgici, 2005, Pulmonary involvement in rheumatoid arthritis, Rheumatol Int, 25, 429, 10.1007/s00296-004-0472-y

Mori, 2008, Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis, J Rheumatol, 35, 1513

Dawson, 2001, Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests, Thorax, 56, 622, 10.1136/thorax.56.8.622

Young, 2007, Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis, Rheumatology (Oxford), 46, 350, 10.1093/rheumatology/kel253

Thomas, 2003, National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study, J Rheumatol, 30, 958

Suzuki, 1994, Cause of death in 81 autopsied patients with rheumatoid arthritis, J Rheumatol, 21, 33

Sihvonen, 2004, Death rates and causes of death in patients with rheumatoid arthritis: a population-based study, Scand J Rheumatol, 33, 221, 10.1080/03009740410005845

Turesson, 1999, Extra-articular rheumatoid arthritis: prevalence and mortality, Rheumatology (Oxford), 38, 668, 10.1093/rheumatology/38.7.668

Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med, 188, 733, 10.1164/rccm.201308-1483ST

Nakamura, 2012, Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases, Respir Med, 106, 1164, 10.1016/j.rmed.2012.04.004

Kim, 2010, Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease, Eur Respir J, 35, 1322, 10.1183/09031936.00092309

Solomon, 2012, Rheumatoid arthritis-associated interstitial lung disease, Open Access Rheumatol Res Rev, 21

Charles, 1991, HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis, Dis Markers, 9, 97

Scott, 1987, HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis, Am J Med, 82, 765, 10.1016/0002-9343(87)90013-1

Hillarby, 1993, HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease, Br J Rheumatol, 32, 794, 10.1093/rheumatology/32.9.794

Sugiyama, 1994, Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54, Intern Med, 33, 612, 10.2169/internalmedicine.33.612

Gochuico, 2008, Progressive preclinical interstitial lung disease in rheumatoid arthritis, Arch Intern Med, 168, 159, 10.1001/archinternmed.2007.59

Albano, 2001, Cigarette smoking and rheumatoid arthritis, Semin Arthritis Rheum, 31, 146, 10.1053/sarh.2001.27719

Demoruelle, 2014, When and where does inflammation begin in rheumatoid arthritis?, Curr Opin Rheumatol, 26, 64, 10.1097/BOR.0000000000000017

Makrygiannakis, 2008, Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells, Ann Rheum Dis, 67, 1488, 10.1136/ard.2007.075192

Willis, 2013, Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease, Arthritis Rheum, 65, 2545, 10.1002/art.38066

Harlow, 2013, Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease, Arthritis Rheum, 65, 869, 10.1002/art.37881

Giles, 2014, Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease, Ann Rheum Dis, 73, 1487, 10.1136/annrheumdis-2012-203160

Chen, 2015, Biomarkers of rheumatoid arthritis-associated interstitial lung disease, Arthritis Rheum, 67, 28, 10.1002/art.38904

Olson, 2011, Rheumatoid arthritis-interstitial lung disease-associated mortality, Am J Respir Crit Care Med, 183, 372, 10.1164/rccm.201004-0622OC

Bongartz, 2010, Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study, Arthritis Rheum, 62, 1583, 10.1002/art.27405

Solomon, 2013, Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), Respir Med, 107, 1247, 10.1016/j.rmed.2013.05.002

Assayag, 2014, Predictors of mortality in rheumatoid arthritis-related interstitial lung disease, Respirology, 19, 493, 10.1111/resp.12234

Park, 2007, Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes, Am J Respir Crit Care Med, 175, 705, 10.1164/rccm.200607-912OC

Perez, 1998, Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings, Am J Respir Crit Care Med, 157, 1658, 10.1164/ajrccm.157.5.9710018

Fischer, 2013, Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease, J Rheumatol, 40, 640, 10.3899/jrheum.121043

Swigris, 2006, Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease, Chest, 130, 30, 10.1016/S0012-3692(15)50949-5

Keir, 2014, Rituximab in severe, treatment-refractory interstitial lung disease, Respirology, 19, 353, 10.1111/resp.12214

Braun-Moscovici, 2013, Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience, Rheumatol Int, 33, 1495, 10.1007/s00296-012-2587-x

Chang, 2002, Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report, J Korean Med Sci, 17, 270, 10.3346/jkms.2002.17.2.270

Puttick, 1995, Treatment of progressive rheumatoid interstitial lung disease with cyclosporine, J Rheumatol, 22, 2163

Bargagli, 2004, Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis, Eur Respir J, 24, 708, 10.1183/09031936.04.00076904

Vassallo, 2002, Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition, Chest, 122, 1093, 10.1378/chest.122.3.1093

Lindsay, 2006, Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment, Rheumatology (Oxford), 45, 1048, 10.1093/rheumatology/kel090

Ostor, 2004, Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab, BMJ, 329, 1266, 10.1136/bmj.329.7477.1266

Dixon, 2010, Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register, Ann Rheum Dis, 69, 1086, 10.1136/ard.2009.120626

Yazdani, 2014, Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation, J Heart Lung Transplant, 33, 514, 10.1016/j.healun.2014.01.858

Geddes, 1979, Airways obstruction in rheumatoid arthritis, Ann Rheum Dis, 38, 222, 10.1136/ard.38.3.222

Collins, 1976, Obstructive pulmonary disease in rheumatoid arthritis, Arthritis Rheum, 19, 623, 10.1002/art.1780190316

Hassan, 1994, Bronchial reactivity and airflow obstruction in rheumatoid arthritis, Ann Rheum Dis, 53, 511, 10.1136/ard.53.8.511

Brazeau-Lamontagne, 1986, Cricoarytenoiditis: CT assessment in rheumatoid arthritis, Radiology, 158, 463, 10.1148/radiology.158.2.3941873

Metafratzi, 2007, Pulmonary involvement in patients with early rheumatoid arthritis, Scand J Rheumatol, 36, 338, 10.1080/03009740701393957

Kochbati, 2003, Bronchiectasis in rheumatoid arthritis. High resolution computed pulmonary tomography, Tunis Med, 81, 768

Geri, 2011, Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases, BMC Infect Dis, 11, 304, 10.1186/1471-2334-11-304

Pipavath, 2005, Radiologic and pathologic features of bronchiolitis, AJR Am J Roentgenol, 185, 354, 10.2214/ajr.185.2.01850354

Fernandez Perez, 2013, FEV1 over time in patients with connective tissue disease-related bronchiolitis, Respir Med, 107, 883, 10.1016/j.rmed.2013.02.019

Devouassoux, 2009, Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis, Eur Respir J, 33, 1053, 10.1183/09031936.00091608

Anaya, 1995, Pulmonary involvement in rheumatoid arthritis, Semin Arthritis Rheum, 24, 242, 10.1016/S0049-0172(95)80034-4

Walters, 1986, Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients, Med J Aust, 144, 648, 10.5694/j.1326-5377.1986.tb112350.x

Morikawa, 1988, Pulmonary hypertension in a patient with rheumatoid arthritis, Chest, 93, 876, 10.1378/chest.93.4.876

Voskuyl, 2003, Diagnostic strategy for the assessment of rheumatoid vasculitis, Ann Rheum Dis, 62, 407, 10.1136/ard.62.5.407

Avnon, 2007, Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?, Rheumatol Int, 27, 919, 10.1007/s00296-007-0322-9

Naylor, 1990, The pathognomonic cytologic picture of rheumatoid pleuritis. The 1989 Maurice Goldblatt Cytology award lecture, Acta Cytol, 34, 465

Kremer, 1997, Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review, Arthritis Rheum, 40, 1829, 10.1002/art.1780401016

Walden, 1977, Pleurisy and methotrexate treatment, Br Med J, 2, 867, 10.1136/bmj.2.6091.867

Cannon, 1983, Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis, Arthritis Rheum, 26, 1269, 10.1002/art.1780261015

St Clair, 1985, Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis, Arch Intern Med, 145, 2035, 10.1001/archinte.1985.00360110105023

Gispen, 1987, Toxicity of methotrexate in rheumatoid arthritis, J Rheumatol, 14, 74

Amital, 2011, The lung in rheumatoid arthritis, Presse Med, 40, e31

Barrera, 1994, Methotrexate-related pulmonary complications in rheumatoid arthritis, Ann Rheum Dis, 53, 434, 10.1136/ard.53.7.434

Toussirot, 2009, Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series, J Rheumatol, 36, 2421, 10.3899/jrheum.090030

Peno-Green, 2002, Lung injury linked to etanercept therapy, Chest, 122, 1858, 10.1378/chest.122.5.1858

Dubey, 2009, Bronchospasm associated with anti-TNF treatment, Clin Rheumatol, 28, 989, 10.1007/s10067-009-1169-0

Atzeni, 2013, Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis, Expert Rev Clin Immunol, 9, 649, 10.1586/1744666X.2013.811173

Roubille, 2014, Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review, Semin Arthritis Rheum, 43, 613, 10.1016/j.semarthrit.2013.09.005

Sakai, 2005, Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features, Mod Rheumatol, 15, 173, 10.3109/s10165-005-0387-9

Suissa, 2006, Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis, Arthritis Rheum, 54, 1435, 10.1002/art.21806

Liote, 2010, Rituximab-induced lung disease: a systematic literature review, Eur Respir J, 35, 681, 10.1183/09031936.00080209

Parry, 2002, Sulphasalazine and lung toxicity, Eur Respir J, 19, 756, 10.1183/09031936.02.00267402

Hamadeh, 1992, Sulfasalazine-induced pulmonary disease, Chest, 101, 1033, 10.1378/chest.101.4.1033

Ikegawa, 2011, A case of organizing pneumonia induced by tocilizumab, Intern Med, 50, 2191, 10.2169/internalmedicine.50.5497

Kawashiri, 2012, A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab, Rheumatol Int, 32, 4023, 10.1007/s00296-010-1525-z

Nishimoto, 2004, Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial, Arthritis Rheum, 50, 1761, 10.1002/art.20303